PETMED EXPRESS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PETMED EXPRESS, INC. (PETS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 632.13 thousand shares for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-02.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-06-02
- PETMED EXPRESS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-09-30 was 261.23K shares, a 126.72% increase year-over-year.
- PETMED EXPRESS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-06-30 was 251.19K shares, a 1029.05% increase year-over-year.
- PETMED EXPRESS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-12-31 was 205.22K shares, a 57.47% increase year-over-year.
- PETMED EXPRESS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-09-30 was 115.22K shares, a 358.38% increase year-over-year.
- PETMED EXPRESS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 632.13K shares, a 38.50% decline from fiscal 2025.
- PETMED EXPRESS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.03M shares, a 24.16% increase from fiscal 2024.
- PETMED EXPRESS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 827.86K shares, a 11.00% increase from fiscal 2023.
- PETMED EXPRESS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 745.85K shares, a 237.91% increase from fiscal 2022.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | 632.13K shares 10-K · filed 2026-06-02 | ||||||
| 2025-03-31 | 1.03M shares 10-K · filed 2026-06-02 | ||||||
| 2024-03-31 | 827.86K shares 10-K · filed 2026-06-02 | ||||||
| 2023-03-31 | 745.85K shares 10-K · filed 2025-10-14 | ||||||
| 2022-09-30 | 261.23K shares 10-Q · filed 2022-11-08 | 261.23K shares 10-Q · filed 2022-11-08 | |||||
| 2022-06-30 | 251.19K shares 10-Q · filed 2022-08-02 | ||||||
| 2022-03-31 | 220.73K shares 10-K · filed 2024-06-14 | ||||||
| 2021-12-31 | 205.22K shares 10-Q · filed 2022-02-04 | 205.22K shares 10-Q · filed 2022-02-04 | |||||
| 2021-09-30 | 115.22K shares 10-Q · filed 2022-11-08 | 115.22K shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 22.25K shares 10-Q · filed 2022-08-02 | ||||||
| 2021-03-31 | 20.95K shares 10-K/A · filed 2024-04-15 | ||||||
| 2020-12-31 | 130.33K shares 10-Q · filed 2022-02-04 | 130.33K shares 10-Q · filed 2022-02-04 | |||||
| 2020-09-30 | 25.14K shares 10-Q · filed 2021-11-02 | 25.14K shares 10-Q · filed 2021-11-02 | |||||
| 2020-06-30 | 72.12K shares 10-Q · filed 2021-07-30 | ||||||
| 2020-03-31 | 72.12K shares 10-K · filed 2022-05-24 | ||||||
| 2019-12-31 | 72.12K shares 10-Q · filed 2021-01-26 | 72.12K shares 10-Q · filed 2021-01-26 | |||||
| 2019-09-30 | 76.62K shares 10-Q · filed 2020-11-03 | 76.62K shares 10-Q · filed 2020-11-03 | |||||
| 2019-06-30 | 136.60K shares 10-Q · filed 2020-08-03 | ||||||
| 2019-03-31 | 126.75K shares 10-K · filed 2021-05-25 | 150.02K shares 10-K · filed 2019-05-28 | |||||
| 2018-12-31 | 127.32K shares 10-Q · filed 2020-01-28 | 127.32K shares 10-Q · filed 2020-01-28 | 77.60K shares 10-Q · filed 2019-01-29 | ||||
| 2018-09-30 | 46.87K shares 10-Q · filed 2019-10-30 | 46.87K shares 10-Q · filed 2019-10-30 | |||||
| 2018-06-30 | 77.35K shares 10-Q · filed 2019-07-30 | ||||||
| 2018-03-31 | 77.35K shares 10-K · filed 2020-05-26 | ||||||
| 2017-12-31 | 127.32K shares 10-Q · filed 2019-01-29 | 77.60K shares 10-Q · filed 2018-01-30 | 7.76K shares 10-Q · filed 2019-01-29 | 77.60K shares 10-Q · filed 2018-01-30 | |||
| 2017-09-30 | 79.20K shares 10-Q · filed 2018-10-30 | 79.20K shares 10-Q · filed 2018-10-30 | |||||
| 2016-09-30 | 30.00K shares 10-Q · filed 2017-10-31 | 30.00K shares 10-Q · filed 2017-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |